Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations.
VandenBussche
Heather L
HL
University of Michigan Hospitals and Health Centers (UMHHC), Ann Arbor, USA.
Johnson
Cary E
CE
Yun
Jin
J
Patel
Sima A
SA
D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage / Q000737:chemistry*; D002214:Capsules; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D004339:Drug Compounding; D004355:Drug Stability; D005437:Flucytosine / Q000008:administration & dosage / Q000737:chemistry*; D019999:Pharmaceutical Solutions
D000935:Antifungal Agents; D002214:Capsules; D019999:Pharmaceutical Solutions; D005437:Flucytosine